Target intelligence / Profile preview

NSA2 pseudogene 3 (NSA2P3)

Target
NSA2P3
Molecular classification
Pseudogene
01

Overview

NSA2 pseudogene 3 is a non-coding genomic element resembling the functional NSA2 gene, itself responsible for nucleolar processes and ribosome assembly[1]. As a pseudogene, NSA2P3 may participate in gene regulatory networks at the RNA level, acting as a decoy for microRNAs or generating RNA species capable of modulating the expression of related genes[2][3][5]. There is currently no evidence that NSA2P3 produces protein or serves as a therapeutic target. Most pseudogenes, including NSA2P3, are not directly targeted by drugs but may be relevant to disease via their roles in RNA-based regulatory processes. Important clarification: NSA2P3 is NOT considered a therapeutic target, receptor, enzyme, transporter, or similar druggable entity. It is a pseudogene—genomically similar to NSA2 but lacking clear functional protein-coding capacity or direct pharmacological relevance[1][2][3][4][5].

Other names
NSA2P3
02

Mechanism of action

None established for drugs (pseudogenes are not direct drug targets)

03

Biological functions

Possible regulatory roles at the RNA level, such as:Antisense regulation of parental NSA2 gene expressionDecoy for microRNAs (ceRNA activity)Generation of siRNAs affecting related genes
04

Disease associations

Indirect regulatory roles may exist in diseases, but no direct evidence for NSA2P3:Other pseudogenes are involved in cancer, cardiovascular disease, and neurological diseases via RNA-mediated regulation of parental genes or ceRNA activity
05

Safety considerations

None known; pseudogenes do not pose protein-level safety issues, but potential for off-target effects via RNA if artificially targeted

Beyond the preview

Go deeper on NSA2 pseudogene 3 (NSA2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSA2 pseudogene 3 (NSA2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call